Brevan Howard Capital Management LP
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1512857
ST. HELIER, Y9
Position in ADPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,372,480
-$3,647,298 QoQ
Shares Held
170,928
-53.9% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Brevan Howard Capital Management LP holds $32,347,391 across 20 Diagnostics & Research names. ADPT ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
30,881 | $6,175,891 | |
| 2 | QGEN |
Qiagen N.V.
|
133,177 | $5,332,407 | |
| 3 | DHR |
Danaher Corp /De/
|
21,586 | $4,092,705 | |
| 4 | A |
Agilent Technologies, Inc.
|
35,679 | $4,066,692 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
This page
|
170,928 | $2,372,480 | |
| 6 | RVTY |
Revvity, Inc.
|
26,071 | $2,284,080 | |
| 7 | SHC |
Sotera Health Co
|
127,142 | $1,823,216 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
7,723 | $1,317,080 |
All Filings in ADPT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,372,480 | 170,928 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,019,778 | 370,676 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $245,972 | 16,442 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $447,381 | 60,213 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $150,240 | 25,061 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||